Observational study focuses on how cancer treatments were associated with two important clinical measures and risk of death in nearly 200 patients with HIV and cancer

New method  means doctors can eliminate precancerous cysts and potentially save lives 

The phase II trial found that over 80 percent of men with prostate cancer whose tumors had mutations in the BRCA genes responded well to treatment with the targeted drug olaparib

A new study suggests that the STAT test order should rest in peace

Recent study finds that one in 20 men with end-stage prostate cancer responded to the immunotherapy pembrolizumab 

New method reduces need for CT scans

Recent research has potential implications for the diagnosis and treatment of this life-threatening condition

Better definition could lead to better diagnosis and treatment for rare diseases that cumulatively affect millions

Researchers reported findings for how two subtypes of pancreatic cancer respond to treatments differently 

As of Nov. 12, 36 confirmed cases of EEE had been reported by eight states; 13 of these cases were fatal